NOVARTIS AG CEDEAR EAC 4 REP 1(USD) financial statements, including revenue, expenses, profit, and loss
The total revenue of NVSD for the last quarter is 13.11 B USD, and it's 4.15% higher compared to the previous quarter. The net income of Q3 24 is 3.26 B USD.